Evidence map›Paper›PMID 30152022›Full record

ArticleThe Journal of physiology2018

Nitric oxide-dependent attenuation of noradrenaline-induced vasoconstriction is impaired in the canine model of Duchenne muscular dystrophy.

Kasun Kodippili, Chady H Hakim, Hsiao T Yang, Xiufang Pan, N Nora Yang, Maurice H Laughlin, Ronald L Terjung, Dongsheng Duan

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Canine Model of Duchenne Muscular Dystrophy.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Intramuscular blood flow in Duchenne and Becker Muscular Dystrophy: Quantitative power Doppler sonography relates to disease severity.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2020
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Kasun KodippiliDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.
Chady H HakimDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.
Hsiao T YangDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.
Xiufang PanDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.
N Nora YangNational Center for Advancing Translational Sciences (NCATS), Bethesda, MD, USA.
Maurice H LaughlinDepartment of Veterinary Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA.
Ronald L TerjungDepartment of Veterinary Biomedical Sciences, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA.
Dongsheng DuanDepartment of Molecular Microbiology and Immunology, University of Missouri, Columbia, MO, USA.ORCID 0000-0003-4109-1132
Missouri College · USNational Center for Advancing Translational Sciences · USUniversity of Missouri · US

Funding

Whole body single AAV microgene therapy in canine DMDR01NS090634 · NINDS · UNIVERSITY OF MISSOURI-COLUMBIA · PI Dongsheng Duan · 2015 to 2026
$4.2M
Treatment of Duchenne Muscular Dystrophy with the Muscle Calcium PumpR01AR070517 · NIAMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI DUAN, DONGSHENG · 2016 to 2020
$3.1M
R16/17-Independent nNOS Anchoring MechanismR21AR067985 · NIAMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI DUAN, DONGSHENG · 2016 to 2017
$355k
HHS | National Institutes of Health (NIH) AR-67985HHS | National Institutes of Health (NIH) NS-90634NIAMS NIH HHS R01 AR070517NIAMS NIH HHS R21 AR067985NINDS NIH HHS R01 NS090634U.S. Department of Defense (DOD) MD130014
6 · The paper itself

Abstract

key pointsWe developed a novel method to study sympatholysis in dogs. We showed abolishment of sarcolemmal nNOS, and reduction of total nNOS and total eNOS in the canine Duchenne muscular dystrophy (DMD) model. We showed sympatholysis in dogs involving both nNOS-derived NO-dependent and NO-independent mechanisms. We showed that the loss of sarcolemmal nNOS compromised sympatholysis in the canine DMD model. We showed that NO-independent sympatholysis was not affected in the canine DMD model. ABSTRACT: The absence of dystrophin in Duchenne muscular dystrophy (DMD) leads to the delocalization of neuronal nitric oxide synthase (nNOS) from the sarcolemma. Sarcolemmal nNOS plays an important role in sympatholysis, a process of attenuating reflex sympathetic vasoconstriction during exercise to ensure blood perfusion in working muscle. Delocalization of nNOS compromises sympatholysis resulting in functional ischaemia and muscle damage in DMD patients and mouse models. Little is known about the contribution of membrane-associated nNOS to blood flow regulation in dystrophin-deficient DMD dogs. We tested the hypothesis that the loss of sarcolemmal nNOS abolishes protective sympatholysis in contracting muscle of affected dogs. Haemodynamic responses to noradrenaline in the brachial artery were evaluated at rest and during contraction in the absence and presence of NOS inhibitors. We found sympatholysis was significantly compromised in DMD dogs, as well as in normal dogs treated with a selective nNOS inhibitor, suggesting that the absence of sarcolemmal nNOS underlies defective sympatholysis in the canine DMD model. Surprisingly, inhibition of all NOS isoforms did not completely abolish sympatholysis in normal dogs, suggesting sympatholysis in canine muscle also involves NO-independent mechanism(s). Our study established a foundation for using the dog model to test therapies aimed at restoring nNOS homeostasis in DMD.

Indexed as

VasoconstrictionAnimalsBrachial ArteryDogsFemaleMaleMuscular Dystrophy, DuchenneNitric OxideNitric Oxide Synthase Type INorepinephrineVasoconstrictor AgentsNitric OxideNitric Oxide Synthase Type INorepinephrineVasoconstrictor AgentsAcetylcholineCanine modelDuchenne muscular dystrophyFunctional sympatholysisNitric oxide synthasenoradrenalinevasoconstrictionVasodilatation

Identifiers

PMID30152022
PMCPMC6209760
OpenAlexW2894852275

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.